Rapid communication · 29 May 2025
Conference abstractPublished 2016
Surface modification of islet cells with biocompatible poly-l-glutamic acid
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Type 1 Diabetes mellitus is an auto-immune disease in which the immune system is activated to destroy the pancreatic beta cells. The transplantation of pancreatic islet cells from human cadaver donor to patients is a successful treatment method on condition of using immunosuppressive drugs. However, long term use of immunosuppressive drugs has some adverse side effects. So, transplantation of these islet cells after masking the antigens on the cells surface can solve this problem. Poly amino acids are used in many biomedical areas. In this study, biocompatible poly-L-glutamic acid (PLGA) was used for surface modification of islet cells. Covalent interactions were provided with PLGA polymer. For this, carboxylic acid groups contained in this polymer was activated and their structures were elucidated by FT-IR and NMR analysis. The amide bond-forming was provided between these activated polymers and amine groups of lysine amino acid residues on the islet cell surface. In-vitro viability of islet cells and insulin secretion were assessed in both control and experimental group as a response of exposure to cytokine combination. Optimum PLGA concentration was found 2mg/mL. Viability and insulin secretion results of surface modification group islet cells with 48 hours cytokine exposure (%59.1; 6.8) were better than islet cells of control group (%47.7; 4.7) (p<0.001). Islet cells, obtained from rats were transplanted to diabetic mice. Surface modification has provided protection against immune response which was determined with monitoring blood glucose level. This method can be considered a promising method for islet cell transplantation.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Diabetes & Metabolism.
Rapid communication · 29 May 2025
Genetic and epigenetic markers for gdm risk
Short communication · 29 May 2025
Metabolic syndrome: Diet, timed eating, supplements
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Diabetes & Metabolism
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Sercan Mercan”
- BylineArticles whose byline prints “Fatma Arslan”
